Aurobindo Pharma has informed that the Nomination and Remuneration/Compensation Committee of the Company on January 19, 2016 has allotted 855,000 equity shares of Re 1 each under ESOP Scheme of the Company. Consequent to the allotment, the paid up share capital of the Company has increased from 583,964,550 Equity Shares of Re 1 each to 584,819,550 Equity Shares of Re 1 each.
The above information is a part of company’s filings submitted to BSE.